Grail’s cancer blood test tracks down over 50 types of early-stage disease in study
June 09, 2020 The company’s ongoing Circulating Cell-free Genome Atlas study spans more than 15,000 participants, including those with and without cancer diagnoses. Results presented last year showed the blood test could detect 12 different early-stage cancers — which together account for nearly two-thirds of all cancer deaths in the U.S. — before they had … Read more